Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
National Institutes of Health (NIH)
Information provided by:
St. Jude Children's Research Hospital
ClinicalTrials.gov Identifier:
NCT00187031
First received: September 12, 2005
Last updated: June 3, 2008
Last verified: June 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: No date given